OBJECTIVES: This study was performed to describe what clinical rheumatologists currently use musculoskeletal ultrasound (MSUS) for, how they are currently training and is the first study to survey rheumatologists to determine their preferences for MSUS training implementation. METHODS: 250 questionnaires were distributed at the British Society of Rheumatology Annual General Meeting (BSR AGM), 2005. RESULTS: 126 (50%) of questionnaires were completed by UK rheumatologists and were analysed. 117 (93%) of the respondents use MSUS imaging for patient management, with 41 (33%) indicating they perform MSUS themselves. Only two (2%) performed MSUS for >5 years. Rheumatologists use MSUS to image all peripheral joints-particularly the hands and feet-to assess joint and soft tissue inflammation and to guide joint injections. Lack of training in MSUS was the principal reason for not performing MSUS. Respondents expressed a preference for future training to be via a programme of regular sessions, with training delivered by either consultant radiologists or rheumatologists. Mentoring was the educational tool and assessment method of choice. CONCLUSIONS: The majority of respondents use MSUS in the management of their patients, with a third performing MSUS themselves. The report indicates rheumatologists' preferences on how training should be delivered in the future.
OBJECTIVES: This study was performed to describe what clinical rheumatologists currently use musculoskeletal ultrasound (MSUS) for, how they are currently training and is the first study to survey rheumatologists to determine their preferences for MSUS training implementation. METHODS: 250 questionnaires were distributed at the British Society of Rheumatology Annual General Meeting (BSR AGM), 2005. RESULTS: 126 (50%) of questionnaires were completed by UK rheumatologists and were analysed. 117 (93%) of the respondents use MSUS imaging for patient management, with 41 (33%) indicating they perform MSUS themselves. Only two (2%) performed MSUS for >5 years. Rheumatologists use MSUS to image all peripheral joints-particularly the hands and feet-to assess joint and soft tissue inflammation and to guide joint injections. Lack of training in MSUS was the principal reason for not performing MSUS. Respondents expressed a preference for future training to be via a programme of regular sessions, with training delivered by either consultant radiologists or rheumatologists. Mentoring was the educational tool and assessment method of choice. CONCLUSIONS: The majority of respondents use MSUS in the management of their patients, with a third performing MSUS themselves. The report indicates rheumatologists' preferences on how training should be delivered in the future.
Authors: M Backhaus; G R Burmester; T Gerber; W Grassi; K P Machold; W A Swen; R J Wakefield; B Manger Journal: Ann Rheum Dis Date: 2001-07 Impact factor: 19.103
Authors: A Taggart; E Filippucci; G Wright; A Bell; A Cairns; G Meenagh; A Pendleton; M Rooney; S Wright; A Grey; W Grassi Journal: Rheumatology (Oxford) Date: 2005-11-01 Impact factor: 7.580
Authors: Marwin Gutierrez; Cristina Hernandez-Diaz; Lucio Ventura-Rios; Lina María Saldarriaga-Rivera; Santiago Ruta; Magaly Alva; Claudia Mora -Trujillo; Wilkerson Pérez; Henry Terrazas; Rodolfo Del Carmen Arape Toyo; Maritza Quintero; Carla Solano; Oscar Sedano Santiago; Janet Grisel Huamán Sotomayor; Cesar Cefferino; Guillermo E Py; Marcelo J Audisio; Walter Javier Spindler; Horacio Berman; Carla Airoldi; Rómulo Wong; Ana Laura Álvarez Del Castillo Araujo; Mario E Díaz; Carmen Cerón Villaquiran; Rubén Darío Mantilla; José Alexandre Mendonça; Inês Guimarães da Silveira; Aline Defaveri do Prado; Melissa Cláudia Bisi; Violeta Rosario; Jeannette Medrano-Sánchez; Roberto Muñoz-Louis; Ana Cecilia Lozada-Navarro; Araceli Bernal; Maribel Lozano; Carlos Pineda Journal: Clin Rheumatol Date: 2016-08-30 Impact factor: 2.980
Authors: Christina Duftner; Claudia Schüller-Weidekamm; Peter Mandl; Thomas Nothnagl; Michael Schirmer; Franz Kainberger; Klaus Machold; Christian Dejaco Journal: Rheumatol Int Date: 2013-09-26 Impact factor: 2.631
Authors: Peter Mandl; Asta Baranauskaite; Nemanja Damjanov; Maja Hojnik; Reka Kurucz; Orsolya Nagy; Petr Nemec; Dora Niedermayer; Porin Perić; Tzvetanka Petranova; Andres Pille; Simona Rednic; Violeta Vlad; Martin Zlnay; Peter V Balint Journal: Rheumatol Int Date: 2016-02-29 Impact factor: 2.631
Authors: Peter Mandl; Anna Ciechomska; L Terslev; Xenofon Baraliakos; P G Conaghan; Maria Antonietta D'Agostino; Annamaria Iagnocco; Conny J van der Laken; Mikkel Ostergaard; E Naredo Journal: RMD Open Date: 2019-06-25